ebomi
Colour theme
Sign in
Insider · CIK 0001379222

Hutson Nancy J

CIK 0001379222 Name as filed on the most recent filing

Filed as Hutson Nancy J (30)

33 transaction lines · from 30 filings · filed 2007-03-13 to 2024-12-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

33 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-12-13 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 52,780, disposed Open Form 4 filing 0001127602-24-029494
2024-05-20 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 31,900, acquired Open Form 4 filing 0001127602-24-016190
2023-10-03 P, Open-market purchase Clearside Biomedical, Inc.CLSD 8,600, acquired Open Form 4 filing 0001209191-23-052027
2023-06-14 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 103,443, disposed Open Form 4 filing 0001127602-23-018775
2022-11-17 P, Open-market purchase Clearside Biomedical, Inc.CLSD 39,900, acquired Open Form 4 filing 0001209191-22-058025
2021-10-15 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 1,617,000, disposed Open Form 4 filing 0001127602-21-027342
2021-08-18 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 9,240, acquired Open Form 4 filing 0001169245-22-000067
2021-08-18 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 9,240, acquired Open Form 4 filing 0001169245-21-000083
2021-08-16 P, Open-market purchase Clearside Biomedical, Inc.CLSD 17,040, acquired Open Form 4 filing 0001209191-21-051883
2021-06-10 S, Open-market sale Biocryst Pharmaceuticals IncBCRX 393,394, disposed Open Form 4 filing 0001127602-21-019792
2021-03-12 P, Open-market purchase Clearside Biomedical, Inc.CLSD 15,525, acquired Open Form 4 filing 0001209191-21-020488
2020-05-20 P, Open-market purchase Clearside Biomedical, Inc.CLSD 9,250, acquired Open Form 4 filing 0001209191-20-031325
2019-11-18 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 14,500, acquired Open Form 4 filing 0001127602-19-033022
2018-12-17 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 4,460, acquired Open Form 4 filing 0001209191-18-062934
2018-11-15 S, Open-market sale Endo International plcENDP 128,300, disposed Open Form 4 filing 0001209191-18-058924
2017-03-09 S, Open-market sale Endo International plcENDP 57,617, disposed Open Form 4 filing 0001209191-17-019749
2016-03-01 S, Open-market sale Endo International plcENDP 143,994, disposed Open Form 4 filing 0001209191-16-105830
2015-02-20 P, Open-market purchase Biocryst Pharmaceuticals IncBCRX 102,700, acquired Open Form 4 filing 0001127602-15-007601
2014-08-18 S, Open-market sale Cubist Pharmaceuticals IncCBST 585,000, disposed Open Form 4 filing 0001127602-14-025794
2014-03-10 S, Open-market sale Endo International plcENDP 360,600, disposed Open Form 4 filing 0001209191-14-019574
2013-07-26 S, Open-market sale Cubist Pharmaceuticals IncCBST 269,350, disposed Open Form 4 filing 0001127602-13-023584
2013-04-26 S, Open-market sale Cubist Pharmaceuticals IncCBST 231,131, disposed Open Form 4 filing 0001127602-13-014568
2013-01-28 S, Open-market sale Cubist Pharmaceuticals IncCBST 216,340, disposed Open Form 4 filing 0001127602-13-003199
2012-10-26 S, Open-market sale Cubist Pharmaceuticals IncCBST 217,615, disposed Open Form 4 filing 0001127602-12-029212
2011-10-26 P, Open-market purchase Cubist Pharmaceuticals IncCBST 2 lines 57,985, acquired Open Form 4 filing 0001127602-11-027825
2010-12-07 P, Open-market purchase Endo Pharmaceuticals Holdings IncENDP 36,380, acquired Open Form 4 filing 0001209191-10-059443
2010-11-09 P, Open-market purchase Inspire Pharmaceuticals IncISPH 2 lines 48,914, acquired Open Form 4 filing 0001181431-10-055080
2009-05-13 P, Open-market purchase Endo Pharmaceuticals Holdings IncENDP 48,930, acquired Open Form 4 filing 0001209191-09-027057
2008-10-23 P, Open-market purchase Cubist Pharmaceuticals IncCBST 2 lines 42,070, acquired Open Form 4 filing 0001210238-08-000005
2007-03-12 P, Open-market purchase Inspire Pharmaceuticals IncISPH 49,529, acquired Open Form 4 filing 0001181431-07-018868

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 20
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Hutson Nancy J, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001379222

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.